Showing results (61-70 of 219) with videos related to
Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2007
Trastuzumab-related cardiotoxicity: calling into question the concept of reversibilityMelinda L Telli, Sharon A Hunt, Robert W Carlson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Solid malignancies in individuals with Down syndrome: a case presentation and literature reviewScott V Bratman, Kathleen C Horst, Robert W Carlson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2021
NCCN Policy Summit: Innovative Solutions to Drive Down Healthcare Costs: Implications for Access to High-Quality Cancer CareTerrell Johnson, Michelle McMurry-Heath, Ted Okon, et al.Clinical Breast Cancer|March 8, 2005
Predictors of local recurrence after breast-conservation therapyKathleen C Horst, Melanie C Smitt, Don R Goffinet, et al.Cancer|September 3, 2011
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancerAna P Kiess, Heather L McArthur, Kathleen Mahoney, et al.International Journal of Radiation Oncology, Biology, Physics|November 14, 2009
Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinomaFrank Vicini, Kathryn Winter, John Wong, et al.International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
Cardiorespiratory Fitness in Patients With Early-Stage Breast Cancer and Radiation Therapy-Related Fatigue: A Prospective Pilot StudyJonathan E Leeman, Kaitlyn Lapen, Hannah E Fuchs, et al.International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319Frank Vicini, Kathryn Winter, William Straube, et al.Annals of Surgical Oncology|July 2, 2015
The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy RadiationT Jonathan Yang, Monica Morrow, Shanu Modi, et al.International Journal of Radiation Oncology, Biology, Physics|February 26, 2008
A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17Douglas W Arthur, Kathryn Winter, Robert R Kuske, et al.Pageof 22